1. Home
  2. Live Updates
  3. Fixed dose combination

Live Breaking News & Updates on Fixed dose combination

Stay informed with the latest breaking news from Fixed dose combination on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Fixed dose combination and stay connected to the pulse of your community

India's pharma market maintains 10% growth despite disruptions; set for 8-10% growth with price hikes, new launches, HDFC sec report

India's Pharma Market (IPM) maintains a solid ~10% CAGR from FY12 to FY23, facing disruptions but showing resilience.

India , Mehul-sheth , National-list-of-essential-medicines , Research-analyst , Services-tax , India-pharma-market , Compounded-annual-growth-rate , National-list , Essential-medicines , Fixed-dose-combination , Target-price ,

FDA Approves Expanded Indication for Bikatarvy for HIV Treatment

The new indication includes individuals with HIV who have suppressed viral loads with known or suspected M184V/I resistance.

Paule-sax , Jared-baeten , Tenofovir-alafenamide , Gilead-sciences , Division-of-infectious-diseases , Gilead-sciences-inc , Clinical-development-at-gilead-sciences , Fixed-dose-combination , Human-immunodeficiency-virus-type , Infected-adults-who-are-virologically , Infectious-diseases ,

Hepatitis C Drug Market To Reach USD 26.9 Billion By 2032 Report By Datahorizzon Research

Hepatitis C Drug Market To Reach USD 26.9 Billion By 2032 Report By Datahorizzon Research
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-states , Fort-collins , Colorado , America , Aurobindo-pharma , Asia-pacific , Linkedin , Abbvie-inc , Bristol-myers-squibb-company , Gilead-sciences , Teva-pharmaceuticals-industries-ltd , Roche-holding

Central drug regulator cracks down on FDCs

In 2012, a parliamentary standing committee of the health ministry had observed in its report that some of the state licensing authorities issued manufacturing licences for a large number of FDCs without prior clearance from the central drug authority, resulting in the availability of several FDCs which were not tested for safety and efficacy.

India , Karnataka , University-in-karnataka , University-college-of-medical-sciences , Drug-controller-general , University-college , Medical-sciences , Imipramine-hydrochloride , Ammonium-chloride , Sodium-citrate , Drug-regulator

Hawaiian Eye and Retina Meeting: Comprehensive meeting in a setting beyond compare

Hawaiian Eye and Retina 2024 meetings will take place from January 13 to 19 at the Grand Wailea Maui, 3850 Wailea Alanui Drive, Wailea, HI.

Hawaii , United-states , Hawaiian , Richard-lindstrom , Image-credit , Hawaiian-eye , Grand-wailea-maui , Alanui-drive , Combined-general-sessions , Functional-eyelid-surgery , Aesthetic-oculoplastics

Deanxit: The story of a drug that India has failed to ban

The Centre banned the sale of Deanxit, a contested psychiatric drug approved without clinical data. But 10 years on, it continues to be sold by other companies.

India , Trinidad-and-tobago , Pakistan , Karnataka , Cyprus , United-states , Delhi , Kenya , Aruba , Jordan , Canada , Lebanon

Fixed dose combination ARVs rolled out

Ga-Rankuwa – About 180 000 HIV positive patients are expected to start on the

Gauteng , South-africa , Aaron-motsoaledi , Andrew-mosane , Treatment-action-campaign , Department-of-health , Community-health-clinic , Fixed-dose-combination , Minister-dr-aaron-motsoaledi , Health-clinic , Child-transmission , Ga-rankuwa-zone

Govt Bans Common Cold And Flu Syrups For Kids Below 4 Yrs, Asks Pharma Companies To Insert Warnings

Pharma firms manufacturing GlaxoSmithKline’s T-Minic Oral Drops, Glenmark’s Ascoril Flu Syrup, and IPCA Laboratories’ Solvin Cold Syrup, among others, have been asked by the regulator to insert a ‘warning’. - Govt Bans Common Cold And Flu Syrups For Kids Below 4 Yrs, Asks Pharma Companies To Insert Warnings | Check List

New-delhi , Delhi , India , Rajeev-singh-raghuvanshi , Ipca-laboratories-ltd-solvin-cold , Glenmark-pharmaceuticals-ltd-ascoril-flu , Alembic-pharmaceuticals-ltd-wikoryl , Wanbury-ltd-coriminic , Glaxo-smithkline-pharmaceuticals-ltdt-minic , World-health-organization , Union-territories , Central-drugs-standard-control-organisation

Take note! Popular anti-cold fixed drug combination banned by Centre for children under 4 years

India's drug regulator has prohibited the use of a popular anti-cold medicine cocktail for children under the age of four. The drug regulator advised

India , Glaxosmithkline , Alembic-pharma , Phenylephrine-hci-ip , Glenmark , Fixed-dose-combination , Drug-regulator , Chlorpheniramine-maleate , Anti-cold-medicine ,

Drug regulator issues warning against cold medication for children under 4 yrs

The the Subject Expert Committee of the Central Drugs Standard Control Organisation recommended a precautionary measure, suggesting that the FDC should not be administered to children below 4 years

Drug-administration , Central-drugs-standard-control-organisation , Professor-kokate-committee , Nonprescription-drugs-advisory-committee , During-the-subject-expert-committee-pulmonary , Fixed-dose-combination , Chlorpheniramine-maleate , Subject-expert-committee , Professor-kokate , Cough-syrup , Ndia